NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 133 filers reported holding NEWLINK GENETICS CORP in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | -99.2% | 2,656 | -99.0% | 0.00% | – |
| Q1 2019 | $521,000 | -63.9% | 269,719 | -71.6% | 0.00% | – |
| Q4 2018 | $1,444,000 | -47.8% | 950,496 | -17.8% | 0.00% | -100.0% |
| Q3 2018 | $2,765,000 | +24.8% | 1,156,871 | +148.7% | 0.00% | – |
| Q2 2018 | $2,215,000 | -38.1% | 465,220 | -5.7% | 0.00% | -100.0% |
| Q1 2018 | $3,577,000 | +6067.2% | 493,367 | +6778.1% | 0.00% | – |
| Q4 2017 | $58,000 | +866.7% | 7,173 | +1008.7% | 0.00% | – |
| Q3 2017 | $6,000 | +50.0% | 647 | +16.6% | 0.00% | – |
| Q2 2017 | $4,000 | -86.7% | 555 | -56.3% | 0.00% | – |
| Q1 2017 | $30,000 | +650.0% | 1,271 | +202.6% | 0.00% | – |
| Q4 2016 | $4,000 | – | 420 | +5900.0% | 0.00% | – |
| Q4 2015 | $0 | – | 7 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 93,533 | $962,000 | 1.69% |
| WALL STREET ASSOCIATES | 108,900 | $1,119,000 | 0.74% |
| NORTHWEST WEALTH MANAGEMENT, LLC | 57,482 | $591,000 | 0.60% |
| Orbimed Advisors | 1,991,700 | $20,475,000 | 0.26% |
| TFS CAPITAL LLC | 92,041 | $946,000 | 0.25% |
| Intrinsic Edge Capital Management LLC | 40,000 | $411,000 | 0.18% |
| SECOR Capital Advisors, LP | 100,529 | $1,033,000 | 0.13% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 176,077 | $1,810,000 | 0.12% |
| Piermont Capital Management Inc. | 41,400 | $426,000 | 0.10% |
| Vident Investment Advisory, LLC | 67,209 | $691,000 | 0.08% |